Consent-First Architecture
ReLive starts with explicit, revocable consent. Data scope is user-defined, and access is governed by family and policy boundaries.
ReLive Genomics works at the intersection of computational biology and AI, with a public commitment to consent-first design, staged privacy workflows, and responsible long-term deployment.
ReLive starts with explicit, revocable consent. Data scope is user-defined, and access is governed by family and policy boundaries.
Signals are preprocessed locally, reviewed by users in the companion app, and only approved summaries and selected data move to datacenter training workflows.
Guardrails, topic boundaries, transparency logs, and grief-aware interaction pacing are built into the product experience from day one.
ReLive Genomics is the company platform. Eterno is Product 1. Future products expand memory and computational biology capabilities on the same ethical core.
Applied research is paired with responsible rollout through trusted channels, including therapist-informed usage patterns and long-term governance.